2009
DOI: 10.1055/s-0029-1221857
|View full text |Cite
|
Sign up to set email alerts
|

„Glucose-depedent Insulinotropic Polypeptide“ (GIP) verstärkt die antidiabetischen Wirkungen von "Glucagon-Like Peptide-1" (GLP-1) bei hyperglykämischen Patienten mit Typ 2-Diabetes mellitus nicht

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles